Esophagus Cancer Completed Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0032126 (Esophagus Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00193141Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal CancerTreatment